凌小浩 黄振炎 黄进
(中山市中医院,广东 中山,528400)
中图分类号:R256.14 文献标识码:A 文章编号:1674-7860(2016)18-0013-02 证型:GBDI
【摘 要】目的:探讨补中益气汤治疗肺脾气虚型慢性阻塞性肺疾病患者疗效。方法:从2013年12月—2015年12月广州中医药大学附属中山市中医院呼吸专科门诊和住院部收治的60例肺脾气虚型慢性阻塞性肺疾病患者作为研究对象,随机选取30例设为治疗组,采用中药+茶碱缓释胶囊治疗治疗,将另外30例患者设为对照组,采用茶碱缓释胶囊治疗。对比两组患者的治疗效果。结果:治疗组患者治疗后PaCO2水平与对照组相比明显较低,PaO2水平与对照组相比明显较高,P<0.05。治疗组患者疗后FVC、FEV1、FVC/FEV1与对照组相比明显较高,P<0.05。治疗组患者疗后6 min步行试验距离与对照组相比明显较长,P<0.05。结论:补中益气汤能有效改善患者血气状况及肺功能状况,可在肺脾气虚型慢性阻塞性肺疾病治疗中推广运用。
【关键词】补中益气汤;肺脾气虚型慢性阻塞性肺疾病;疗效
【Abstract】Objective:Toinvestigate the curative effect ofBuzhong YiqiDecoction on patients with lung and spleen deficiency type chronic obstructive pulmonary disease. Method:GuangzhouChinese medicine university attached to Zhongshan Chinese medicine hospitaltreated 60 cases of lung spleen deficiency of chronic obstructive pulmonarydisease patients as research subjects from December 2013 to December 2015 bydividing them randomly into Control Group and Treatment Group with 30 cases ineach group. The treatment group was treated using the traditional Chinese medicine combinedwith theophylline therapy treatment, while the control group was treated usingtheophylline therapy treatment. After the treatment the results between the twogroups were compared. Result: The PaCO2 level in the treatment groupwere significantly lower than that in the control group, the difference wasstatistically important (P<0.05).The FVC, FEV1, FVC/FEV1 score were significantly higher in the treatment groupthan in the control group, P<0.05.The 6min walk experiment distance was significantly longer in the treatmentgroup than the control group, P<0.05.Conclusion: Buzhongyiqitang treatment can effectively improve the patientcourage vigor condition and lung function condition, so it must be promoted for treating patients with lungspleen deficiency with chronic obstructive pulmonary disease.
【Keywords】BuzhongYiqi Decoction; Lung and spleen deficiency type chronic obstructive pulmonarydisease; Curative effect
doi:10.3969/j.issn.1674-7860.2016.18.006
![]() |